启明星辰(002439) - 2023 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2023 was ¥787,681,762.33, representing a 39.56% increase compared to ¥564,406,613.07 in the same period last year[5]. - The net profit attributable to shareholders was -¥65,726,750.98, an improvement of 32.60% from -¥97,510,893.01 year-on-year[5]. - The net profit for Q1 2023 was -67,975,714.74 CNY, compared to -98,314,117.17 CNY in Q1 2022, showing an improvement of approximately 30.7% year-over-year[19]. - The company reported a total comprehensive loss of -68,858,371.30 CNY for Q1 2023, compared to -99,020,855.83 CNY in Q1 2022, marking a reduction in losses of about 30.4%[19]. - The company's basic and diluted earnings per share were both -¥0.07, showing a 36.36% improvement from -¥0.11 in the same period last year[5]. - The basic earnings per share for Q1 2023 were -0.07 CNY, compared to -0.11 CNY in Q1 2022, showing an improvement of approximately 36.4%[19]. Cash Flow and Liquidity - The net cash flow from operating activities was -¥385,677,164.86, a significant decline of 783.07% compared to -¥43,674,374.16 in the previous year[5]. - Cash paid for the acquisition of fixed assets, intangible assets, and other long-term assets in Q1 2023 was ¥29,264,054.02, a decrease of 68.26% compared to the same period last year, primarily due to reduced payments for real estate purchases[11]. - Cash received from other financing activities in Q1 2023 was ¥171,643.53, a significant increase of ¥171,643.53 compared to the same period last year, attributed to interest income from raised funds[11]. - Cash paid for other financing activities in Q1 2023 was ¥11,469,695.58, an increase of 109.45% year-over-year, primarily due to increased lease payments[11]. - The cash and cash equivalents at the end of Q1 2023 were ¥805,699,924.74, down from ¥1,340,148,486.54 at the beginning of the year[15]. - The cash and cash equivalents at the end of Q1 2023 were 761,314,198.25 CNY, down from 1,091,876,629.18 CNY at the end of Q1 2022, a decrease of approximately 30.2%[22]. Assets and Liabilities - The total assets at the end of Q1 2023 were ¥9,783,374,053.85, down 2.19% from ¥10,002,085,275.55 at the end of the previous year[5]. - Current liabilities totaled ¥2,231,328,362.28, down 9.1% from ¥2,455,331,231.43 in the previous year[17]. - Non-current liabilities increased to ¥197,652,557.39, up from ¥136,655,376.23, representing a growth of 44.5%[17]. - The company's total equity decreased slightly to ¥7,354,393,134.18 from ¥7,410,098,667.89, a decline of about 0.8%[17]. - Long-term receivables rose significantly to ¥143,765,157.16, compared to ¥73,205,607.07, marking an increase of 96.3%[17]. - Inventory levels decreased to ¥341,472,821.18 from ¥447,654,924.31, a reduction of 23.6%[16]. Operating Costs and Expenses - The company reported a 116.80% increase in operating costs, amounting to ¥385,274,110.34, attributed to higher service project and third-party product sales costs[8]. - Total operating costs for Q1 2023 were ¥956,467,330.40, up 22.3% from ¥782,131,081.69 in the same period last year[18]. - The company incurred sales expenses of 272,155,973.69 CNY in Q1 2023, a decrease from 309,412,337.65 CNY in the same period last year, reflecting a reduction of about 12.0%[19]. - Research and development expenses increased to 245,557,875.70 CNY in Q1 2023, up from 232,908,093.97 CNY in the same period last year, reflecting a growth of about 5.6%[19]. Government Support and Fair Value Changes - The company received government subsidies totaling ¥37,985,024.69, primarily from VAT refunds[6]. - The fair value change income for Q1 2023 was ¥32,319,607.58, a substantial increase of 242.48% year-on-year, due to the listing of a subsidiary on the STAR Market[9]. Market Outlook - Future outlook includes potential market expansion and new product development strategies to enhance revenue growth[18]. - The company is in the process of issuing shares to specific targets, pending approval from the Shenzhen Stock Exchange and the China Securities Regulatory Commission[14].